MAPK1 and benign prostatic hyperplasia: Silodosin is the treatment of choice for lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).36 Signal transduction in the TK complex via phosphorylation at certain sites in response to MAPKs and ERK.